1. Home
  2. CNTX vs MDAI Comparison

CNTX vs MDAI Comparison

Compare CNTX & MDAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Context Therapeutics Inc.

CNTX

Context Therapeutics Inc.

N/A

Current Price

$0.17

Market Cap

47.7M

Sector

Health Care

ML Signal

N/A

Logo Spectral AI Inc.

MDAI

Spectral AI Inc.

N/A

Current Price

$1.32

Market Cap

48.0M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CNTX
MDAI
Founded
2015
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Medical/Dental Instruments
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
47.7M
48.0M
IPO Year
2021
2021

Fundamental Metrics

Financial Performance
Metric
CNTX
MDAI
Price
$0.17
$1.32
Analyst Decision
Buy
Analyst Count
10
0
Target Price
$3.79
★ $5.11
AVG Volume (30 Days)
★ 1.2M
130.7K
Earning Date
11-10-2026
11-10-2026
Dividend Yield
N/A
N/A
EPS Growth
17.39
★ 65.88
EPS
★ N/A
N/A
Revenue
N/A
★ $19,650,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$74.98
P/E Ratio
N/A
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$0.15
$1.18
52 Week High
$3.62
$2.97

Technical Indicators

Market Signals
Indicator
CNTX
MDAI
Relative Strength Index (RSI) 36.02 34.06
Support Level N/A $1.18
Resistance Level $0.22 $1.72
Average True Range (ATR) 0.02 0.11
MACD 0.00 -0.02
Stochastic Oscillator 33.07 9.09

Price Performance

Historical Comparison
CNTX
MDAI

About CNTX Context Therapeutics Inc.

Context Therapeutics Inc is a clinical-stage biopharmaceutical company advancing medicines for solid tumors. The development team is advancing a pipeline of various therapies with a primary focus on treating female, hormone-dependent cancer, including breast, ovarian, and endometrial cancer. The company's preclinical program, CTIM-76, is an anti-Claudin 6 (CLDN6) x anti-CD3 bispecific antibody (bsAb) that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6.

About MDAI Spectral AI Inc.

Spectral AI Inc is an AI company focused on predictive medical diagnostics. Its DeepView System uses proprietary AI algorithms to distinguish between fully damaged, partially damaged and healthy human tissue characters invisible to the naked eye, at the initial time point of wound presentation. The DeepView System delivers a binary prediction on the wound's capacity to heal or not-heal by a specified time point in the future. The company focuses on the burn indication which is supported by the BARDA PBS contract.

Share on Social Networks: